In recent years, researchers have focused on the role of various adipose tissue depots in the development of coronary artery disease (CAD), extending beyond traditional obesity assessments based on body mass index (BMI). Visceral adipose tissue, epicardial fat, fatty liver disease (currently termed metabolic dysfunction-associated steatotic liver disease), and perivascular adipose tissue actively participate in CAD pathogenesis through mechanisms of systemic inflammation, oxidative stress, endothelial dysfunction, and atherosclerosis. Visceral fat, characterized by high metabolic activity, secretes proinflammatory cytokines that promote insulin resistance and atherosclerosis. Epicardial fat surrounding the coronary arteries exerts local effects by releasing adipokines that may accelerate the progression of atherosclerotic plaques. Fatty liver disease is associated with dyslipidemia and enhanced systemic inflammation, increasing cardiovascular risk. Perivascular adipose tissue regulates vascular tone and inflammation, and its dysfunction contributes to arterial stiffness and hypertension. The relevance of studying these adipose depots lies in the need to identify new biomarkers and targets for personalized prevention and treatment of CAD. Traditional obesity assessment methods such as BMI, fail to reflect adipose tissue distribution and metabolic activity, underscoring the importance of more detailed investigation into the role of various fat depots in cardiovascular pathology.
| Mualliflar | Юсупалиева , Д, Алиева, Р, Ахмедова , Ш, Шек , А, Yusupaliyeva, Dilnora, Aliyeva, Rano, Axmedova , Shoxista, Shek , Aleksandr, Yusupaliyeva, Dilnora, Aliyeva , Rano, Akhmedova , Shokhista, Shek , Aleksandr |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2025-09-30 |
| Jild | 2 |
| Son | 3 |
| Betlar | 248-263 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2025-2-56 |
DOI: 10.70626/cardiouz-2025-2-56 · Maqolaning asl sahifasi
ишемическая болезнь сердца, локальные жировые депо, ожирение, висцеральное ожирение, эпикардиальная жировая ткань, ассоциированная с метаболической дисфункцией стеатозная болезнь печени, периваскулярная жировая ткань, coronary artery disease, local adipose depots, obesity, visceral obesity, epicardial adipose tissue, metabolic dysfunction-associated steatotic liver disease, perivascular adipose tissue, ishemik yurak kasalligi, lokal yog‘ to‘planmalari, semirish, visseral semirish, yurak atrofi (epikardial) yog‘ to‘qimasi, metabolik disfunktsiya bilan bog‘liq steatoz kasalligi, tomir atrofi yog‘ to‘qimasi
Aim. To evaluate the one-year dynamic effect of complete or incomplete revascularization on left ventricular ejection fraction (LVEF) in patients with a history of myocardial infarction (MI) who have preserved or mildly…
Aim. To evaluate the clinical effectiveness and safety of the Ross procedure in children with congenital aortic valve disease. The main aim of the study was to determine the physiological and hemodynamic advantages of…
This review synthesizes current evidence on early biomarkers of endothelial dysfunction (ED) in cardiovascular disease (CVD), emphasizing their role in diagnosis, prognosis, and management. ED, characterized by reduced…
Aim. To evaluate the effectiveness of posterior pericardiotomy in reducing the risk of postoperative supraventricular arrhythmias in patients who underwent off-pump coronary artery bypass grafting. Materials and…
Obstructive hypertrophic cardiomyopathy (OHCMP) is a disease characterized by cardiac remodeling due to genetic factors. OHCMP can cause the development of dynamic obstruction in the outflow tract of the left ventricle…
According to the World Health Organization data, 1.13 billion people worldwide suffer from arterial hypertension, with only 21% under proper control. Dementia currently negatively affects the quality of life of 55…
Aim. To evaluate the effectiveness of ulinastatin as part of complex therapy in reducing the incidence of early postoperative complications in patients with multivessel coronary artery disease after CABG. Materials and…
Sudden Cardiac Death (SCD) is one of the most severe and life-threatening manifestations of cardiovascular diseases and is among the leading causes of mortality worldwide. The primary pathogenic factors contributing to…
Aim. Systematic analysis and comparison of different reperfusion therapy methods in patients with ST-elevation acute coronary syndrome (STEMI), including primary percutaneous coronary intervention (pPCI) and…
Aim. To study the impact of lipoprotein (a) levels on major cardiovascular events. Materials and methods. We examined the impact of lipoprotein(a) levels on major cardiovascular events based on a review of articles on…